Benitec Biopharma Inc. (BNTC)

Benitec Biopharma Balance Sheet

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Cash & Equivalents	97.74	50.87	2.48	4.06	19.77
Cash & Short-Term Investments	97.74	50.87	2.48	4.06	19.77
Cash Growth	92.16%	1953.53%	-39.02%	-79.45%	101.68%
Accounts Receivable	-	-	0.06	0	0.03
Other Receivables	0.03	0.23	-	-	-
Receivables	0.03	0.23	0.06	0	0.03
Prepaid Expenses	0.63	0.52	1.18	0.74	0.8
Restricted Cash	0.11	0.06	0.01	0.01	0.02
Total Current Assets	98.52	51.67	3.73	4.82	20.61
Property, Plant & Equipment	0.99	0.45	0.61	0.99	0.58
Other Long-Term Assets	0.08	0.09	0.12	0.16	0.19
Total Assets	99.59	52.21	4.46	5.97	21.38
Accounts Payable	0.2	1.35	1.14	0.42	0.27
Accrued Expenses	0.52	0.65	0.74	0.7	0.49
Current Portion of Leases	0.35	0.28	0.28	0.25	0.21
Other Current Liabilities	0.72	2.64	1.82	1.16	0.39
Total Current Liabilities	1.8	4.92	3.98	2.53	1.37
Long-Term Leases	0.5	-	0.28	0.56	-
Pension & Post-Retirement Benefits	-	0.04	-	-	-
Total Liabilities	2.3	4.96	4.26	3.09	1.37
Common Stock	0	0	-	-	0
Additional Paid-In Capital	326.31	238.4	168.92	152.45	151.58
Retained Earnings	-228.18	-190.26	-167.89	-148.33	-130.12
Comprehensive Income & Other	-0.84	-0.89	-0.83	-1.25	-1.46
Shareholders' Equity	97.3	47.25	0.2	2.88	20.01
Total Liabilities & Equity	99.59	52.21	4.46	5.97	21.38
Total Debt	0.85	0.28	0.56	0.81	0.21
Net Cash (Debt)	96.9	50.58	1.92	3.25	19.56
Net Cash Growth	91.56%	2537.23%	-41.00%	-83.38%	108.11%
Net Cash Per Share	2.68	2.75	1.38	6.76	77.40
Filing Date Shares Outstanding	26.25	10.56	2.55	0.48	0.48
Total Common Shares Outstanding	26.25	10.09	1.65	0.48	0.48
Working Capital	96.72	46.75	-0.25	2.29	19.24
Book Value Per Share	3.71	4.68	0.12	6.00	41.63
Tangible Book Value	97.3	47.25	0.2	2.88	20.01
Tangible Book Value Per Share	3.71	4.68	0.12	6.00	41.63
Machinery	1.57	1.55	1.38	1.37	1.36
Leasehold Improvements	0.02	0.02	0.02	0.02	0.02

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q